Warfarin in Mitral Stenosis Without Atrial Fibrillation
Anticoagulation with warfarin should be considered in patients with isolated mitral stenosis in sinus rhythm based on specific high-risk features, but is not routinely indicated for all patients without atrial fibrillation.
Clear Indications for Warfarin (Class I Recommendations)
Definite indications where warfarin (INR 2.0-3.0) is strongly recommended 1:
- Prior embolic event - even in sinus rhythm
- Left atrial thrombus documented on imaging
- Rheumatic mitral stenosis with history of systemic embolism 2
Consider Anticoagulation (Class IIb - May Be Considered)
Warfarin may be considered in asymptomatic patients with severe mitral stenosis who have 1:
- Left atrial diameter ≥55 mm by echocardiography (INR target 2.5, range 2.0-3.0) 2, 3
- Spontaneous echo contrast on echocardiography with enlarged left atrium 1
The evidence supporting these conditional recommendations comes from observational data showing that these features predict thromboembolism risk 4, 5.
Risk Stratification Algorithm
Assess the following to determine anticoagulation need:
- History of embolism? → YES = Start warfarin (Class I)
- LA thrombus on TEE? → YES = Start warfarin (Class I)
- Left atrial size ≥55 mm? → YES = Consider warfarin (Class IIb)
- Severe spontaneous echo contrast (grade 3-4+)? → YES = Consider warfarin (Class IIb) 4
- Age and severity of stenosis - older patients with smaller mitral valve area (<1.0 cm²) have higher embolic risk 4, 5
Evidence Supporting Selective Anticoagulation
Recent research demonstrates a hypercoagulable state in patients with severe mitral stenosis in sinus rhythm who have left atrial appendage inactivity and spontaneous echo contrast, with significantly elevated procoagulant levels comparable to those seen in atrial fibrillation 6. This supports consideration of anticoagulation in high-risk subsets.
Key predictive factors for thromboembolism in sinus rhythm patients 4, 5:
- Age (odds ratio 1.14 per year)
- Spontaneous echo contrast grade 3-4+ (odds ratio 46.42)
- Left atrial dilatation
- Severity of mitral stenosis (smaller valve area)
Target INR and Monitoring
When anticoagulation is indicated 3, 7:
- Target INR: 2.5 (range 2.0-3.0)
- Standard intensity anticoagulation is appropriate for mitral stenosis in sinus rhythm
- Recent data in Southeast Asian populations confirms INR 2.0-3.0 is optimal, balancing thromboembolism prevention against bleeding risk 8
Common Pitfalls
Do not routinely anticoagulate all patients with mitral stenosis in sinus rhythm - this increases bleeding risk without proven benefit in low-risk patients 3.
Do perform transesophageal echocardiography when considering anticoagulation decisions, as it identifies left atrial thrombus and quantifies spontaneous echo contrast that transthoracic echo may miss 3.
Reassess anticoagulation need if patient undergoes successful percutaneous mitral balloon valvuloplasty, as improved left atrial mechanics may reduce thrombotic risk 6.
The 2014 AHA/ASA guidelines 1 and 2012 ACCP guidelines 3 provide the strongest framework: mandatory anticoagulation for prior embolism or LA thrombus, selective anticoagulation for high-risk features like severe LA enlargement or dense spontaneous contrast.